HEALTHPEAK PROPERTIES INC (DOC) Stock Fundamental Analysis
USA - NYSE:DOC - US42250P1030 - REIT
17.95 USD
+0.38 (+2.16%)
17.9 USD
-0.05 (-0.28%)
Overall DOC gets a fundamental rating of 3 out of 10. We evaluated DOC against 127 industry peers in the Diversified REITs industry. There are concerns on the financial health of DOC while its profitability can be described as average. DOC is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
DOC had positive earnings in the past year.
In the past year DOC had a positive cash flow from operations.
DOC had positive earnings in each of the past 5 years.
In the past 5 years DOC always reported a positive cash flow from operatings.
1.2 Ratios
DOC's Return On Assets of 0.83% is in line compared to the rest of the industry. DOC outperforms 52.76% of its industry peers.
The Return On Equity of DOC (2.07%) is comparable to the rest of the industry.
DOC has a worse Return On Invested Capital (2.07%) than 61.42% of its industry peers.
DOC had an Average Return On Invested Capital over the past 3 years of 2.19%. This is in line with the industry average of 3.04%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.83% | ||
| ROE | 2.07% | ||
| ROIC | 2.07% |
ROA(3y)2.1%
ROA(5y)2.44%
ROE(3y)5.05%
ROE(5y)5.78%
ROIC(3y)2.19%
ROIC(5y)1.92%
1.3 Margins
DOC has a Profit Margin (5.87%) which is in line with its industry peers.
DOC's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 17.78%, DOC is in line with its industry, outperforming 41.73% of the companies in the same industry.
In the last couple of years the Operating Margin of DOC has declined.
The Gross Margin of DOC (60.51%) is worse than 64.57% of its industry peers.
DOC's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 17.78% | ||
| PM (TTM) | 5.87% | ||
| GM | 60.51% |
OM growth 3Y-2.63%
OM growth 5Y-7.45%
PM growth 3Y-30.28%
PM growth 5Y20.4%
GM growth 3Y0.52%
GM growth 5Y-2.11%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so DOC is destroying value.
Compared to 1 year ago, DOC has more shares outstanding
DOC has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, DOC has about the same debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 0.41, we must say that DOC is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of DOC (0.41) is comparable to the rest of the industry.
The Debt to FCF ratio of DOC is 17.80, which is on the high side as it means it would take DOC, 17.80 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 17.80, DOC is in the better half of the industry, outperforming 77.95% of the companies in the same industry.
DOC has a Debt/Equity ratio of 1.14. This is a high value indicating a heavy dependency on external financing.
DOC's Debt to Equity ratio of 1.14 is in line compared to the rest of the industry. DOC outperforms 54.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.14 | ||
| Debt/FCF | 17.8 | ||
| Altman-Z | 0.41 |
ROIC/WACC0.33
WACC6.36%
2.3 Liquidity
DOC has a Current Ratio of 0.19. This is a bad value and indicates that DOC is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of DOC (0.19) is worse than 92.91% of its industry peers.
A Quick Ratio of 0.19 indicates that DOC may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.19, DOC is doing worse than 92.91% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.19 | ||
| Quick Ratio | 0.19 |
3. Growth
3.1 Past
The earnings per share for DOC have decreased strongly by -57.45% in the last year.
DOC shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 28.47% yearly.
The Revenue has grown by 9.58% in the past year. This is quite good.
The Revenue has been growing by 16.84% on average over the past years. This is quite good.
EPS 1Y (TTM)-57.45%
EPS 3Y-16.9%
EPS 5Y28.47%
EPS Q2Q%-33.33%
Revenue 1Y (TTM)9.58%
Revenue growth 3Y12.51%
Revenue growth 5Y16.84%
Sales Q2Q%0.78%
3.2 Future
DOC is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -2.84% yearly.
DOC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.35% yearly.
EPS Next Y-35.79%
EPS Next 2Y-11.73%
EPS Next 3Y-8.14%
EPS Next 5Y-2.84%
Revenue Next Year3.41%
Revenue Next 2Y3.36%
Revenue Next 3Y3.56%
Revenue Next 5Y5.35%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
DOC is valuated quite expensively with a Price/Earnings ratio of 89.75.
The rest of the industry has a similar Price/Earnings ratio as DOC.
DOC is valuated expensively when we compare the Price/Earnings ratio to 26.10, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 65.82, which means the current valuation is very expensive for DOC.
The rest of the industry has a similar Price/Forward Earnings ratio as DOC.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.52, DOC is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 89.75 | ||
| Fwd PE | 65.82 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, DOC is valued a bit cheaper than 61.42% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, DOC is valued a bit cheaper than the industry average as 74.02% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 24.55 | ||
| EV/EBITDA | 13.34 |
4.3 Compensation for Growth
A cheap valuation may be justified as DOC's earnings are expected to decrease with -8.14% in the coming years.
PEG (NY)N/A
PEG (5Y)3.15
EPS Next 2Y-11.73%
EPS Next 3Y-8.14%
5. Dividend
5.1 Amount
DOC has a Yearly Dividend Yield of 6.94%, which is a nice return.
Compared to an average industry Dividend Yield of 6.35, DOC pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.35, DOC pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.94% |
5.2 History
The dividend of DOC decreases each year by -2.76%.
DOC has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-2.76%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
515.26% of the earnings are spent on dividend by DOC. This is not a sustainable payout ratio.
The Dividend Rate of DOC has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP515.26%
EPS Next 2Y-11.73%
EPS Next 3Y-8.14%
17.95
+0.38 (+2.16%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners96.35%
Inst Owner Change0%
Ins Owners0.22%
Ins Owner Change2.62%
Market Cap12.47B
Revenue(TTM)2.80B
Net Income(TTM)164.00M
Analysts78.33
Price Target21.23 (18.27%)
Short Float %2.26%
Short Ratio1.97
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.94% |
Yearly Dividend1.28
Dividend Growth(5Y)-2.76%
DP515.26%
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.51%
Min EPS beat(2)-19.41%
Max EPS beat(2)12.38%
EPS beat(4)2
Avg EPS beat(4)-2.54%
Min EPS beat(4)-79.16%
Max EPS beat(4)76.02%
EPS beat(8)5
Avg EPS beat(8)13.23%
EPS beat(12)7
Avg EPS beat(12)53.56%
EPS beat(16)10
Avg EPS beat(16)40.84%
Revenue beat(2)1
Avg Revenue beat(2)0.84%
Min Revenue beat(2)-0.37%
Max Revenue beat(2)2.05%
Revenue beat(4)3
Avg Revenue beat(4)0.99%
Min Revenue beat(4)-0.37%
Max Revenue beat(4)2.05%
Revenue beat(8)6
Avg Revenue beat(8)1.97%
Revenue beat(12)7
Avg Revenue beat(12)-4.86%
Revenue beat(16)11
Avg Revenue beat(16)-3.43%
PT rev (1m)-0.36%
PT rev (3m)-5.47%
EPS NQ rev (1m)-4.88%
EPS NQ rev (3m)-11.37%
EPS NY rev (1m)-4.3%
EPS NY rev (3m)-10.1%
Revenue NQ rev (1m)-0.21%
Revenue NQ rev (3m)-0.73%
Revenue NY rev (1m)-0.14%
Revenue NY rev (3m)-0.68%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 89.75 | ||
| Fwd PE | 65.82 | ||
| P/S | 4.46 | ||
| P/FCF | 24.55 | ||
| P/OCF | 10.02 | ||
| P/B | 1.57 | ||
| P/tB | 1.72 | ||
| EV/EBITDA | 13.34 |
EPS(TTM)0.2
EY1.11%
EPS(NY)0.27
Fwd EY1.52%
FCF(TTM)0.73
FCFY4.07%
OCF(TTM)1.79
OCFY9.98%
SpS4.02
BVpS11.41
TBVpS10.43
PEG (NY)N/A
PEG (5Y)3.15
Graham Number7.17
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.83% | ||
| ROE | 2.07% | ||
| ROCE | 2.62% | ||
| ROIC | 2.07% | ||
| ROICexc | 2.08% | ||
| ROICexgc | 2.27% | ||
| OM | 17.78% | ||
| PM (TTM) | 5.87% | ||
| GM | 60.51% | ||
| FCFM | 18.17% |
ROA(3y)2.1%
ROA(5y)2.44%
ROE(3y)5.05%
ROE(5y)5.78%
ROIC(3y)2.19%
ROIC(5y)1.92%
ROICexc(3y)2.2%
ROICexc(5y)1.94%
ROICexgc(3y)2.39%
ROICexgc(5y)2.1%
ROCE(3y)2.77%
ROCE(5y)2.44%
ROICexgc growth 3Y3.4%
ROICexgc growth 5Y2.94%
ROICexc growth 3Y2.73%
ROICexc growth 5Y2.33%
OM growth 3Y-2.63%
OM growth 5Y-7.45%
PM growth 3Y-30.28%
PM growth 5Y20.4%
GM growth 3Y0.52%
GM growth 5Y-2.11%
F-Score6
Asset Turnover0.14
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.14 | ||
| Debt/FCF | 17.8 | ||
| Debt/EBITDA | 5.7 | ||
| Cap/Depr | 67.65% | ||
| Cap/Sales | 26.35% | ||
| Interest Coverage | 1.93 | ||
| Cash Conversion | 78.47% | ||
| Profit Quality | 309.77% | ||
| Current Ratio | 0.19 | ||
| Quick Ratio | 0.19 | ||
| Altman-Z | 0.41 |
F-Score6
WACC6.36%
ROIC/WACC0.33
Cap/Depr(3y)101.04%
Cap/Depr(5y)178.11%
Cap/Sales(3y)35.69%
Cap/Sales(5y)67.36%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-57.45%
EPS 3Y-16.9%
EPS 5Y28.47%
EPS Q2Q%-33.33%
EPS Next Y-35.79%
EPS Next 2Y-11.73%
EPS Next 3Y-8.14%
EPS Next 5Y-2.84%
Revenue 1Y (TTM)9.58%
Revenue growth 3Y12.51%
Revenue growth 5Y16.84%
Sales Q2Q%0.78%
Revenue Next Year3.41%
Revenue Next 2Y3.36%
Revenue Next 3Y3.56%
Revenue Next 5Y5.35%
EBIT growth 1Y-14.85%
EBIT growth 3Y9.55%
EBIT growth 5Y8.14%
EBIT Next Year233.06%
EBIT Next 3Y53.58%
EBIT Next 5Y32.75%
FCF growth 1Y28322.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y34.95%
OCF growth 3Y10.42%
OCF growth 5Y4.82%
HEALTHPEAK PROPERTIES INC / DOC FAQ
Can you provide the ChartMill fundamental rating for HEALTHPEAK PROPERTIES INC?
ChartMill assigns a fundamental rating of 3 / 10 to DOC.
Can you provide the valuation status for HEALTHPEAK PROPERTIES INC?
ChartMill assigns a valuation rating of 2 / 10 to HEALTHPEAK PROPERTIES INC (DOC). This can be considered as Overvalued.
What is the profitability of DOC stock?
HEALTHPEAK PROPERTIES INC (DOC) has a profitability rating of 4 / 10.
Can you provide the financial health for DOC stock?
The financial health rating of HEALTHPEAK PROPERTIES INC (DOC) is 2 / 10.
Can you provide the dividend sustainability for DOC stock?
The dividend rating of HEALTHPEAK PROPERTIES INC (DOC) is 5 / 10 and the dividend payout ratio is 515.26%.